Anixa Biosciences Inc Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q3 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Anixa Biosciences Inc quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q3 2016 to Q3 2024.
  • Anixa Biosciences Inc Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending October 31, 2024 was $18.9M, a 19.2% decline year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $18.9M -$4.48M -19.2% Oct 31, 2024 10-K 2025-01-10
Q2 2024 $20.7M -$3.89M -15.8% Jul 31, 2024 10-Q 2024-09-06
Q1 2024 $22.6M -$3.33M -12.9% Apr 30, 2024 10-Q 2024-09-06
Q4 2023 $23.6M -$3.31M -12.3% Jan 31, 2024 10-Q 2024-06-04
Q3 2023 $23.4M -$4.83M -17.1% Oct 31, 2023 10-K 2025-01-10
Q2 2023 $24.6M -$6.32M -20.5% Jul 31, 2023 10-Q 2024-09-06
Q1 2023 $25.9M -$5.49M -17.5% Apr 30, 2023 10-Q 2024-09-06
Q4 2022 $26.9M -$6.33M -19% Jan 31, 2023 10-Q 2024-06-04
Q3 2022 $28.2M -$6.57M -18.9% Oct 31, 2022 10-K 2025-01-10
Q2 2022 $30.9M -$4.95M -13.8% Jul 31, 2022 10-Q 2023-09-06
Q1 2022 $31.4M -$5.65M -15.2% Apr 30, 2022 10-Q 2023-09-06
Q4 2021 $33.2M +$20.2M +154% Jan 31, 2022 10-Q 2023-06-14
Q3 2021 $34.8M +$26.5M +321% Oct 31, 2021 10-K 2024-01-16
Q2 2021 $35.9M +$27.7M +341% Jul 31, 2021 10-Q 2022-09-09
Q1 2021 $37.1M +$32.2M +668% Apr 30, 2021 10-Q 2022-09-09
Q4 2020 $13.1M +$8.08M +162% Jan 31, 2021 10-Q 2022-06-10
Q3 2020 $8.26M +$3.45M +71.7% Oct 31, 2020 10-K 2023-01-04
Q2 2020 $8.14M +$2.74M +50.7% Jul 31, 2020 10-Q 2021-09-01
Q1 2020 $4.82M -$1.35M -21.8% Apr 30, 2020 10-Q 2021-09-01
Q4 2019 $5M -$146K -2.83% Jan 31, 2020 10-Q 2021-06-10
Q3 2019 $4.81M -$371K -7.16% Oct 31, 2019 10-K 2022-01-04
Q2 2019 $5.4M -$765K -12.4% Jul 31, 2019 10-Q 2020-09-08
Q1 2019 $6.17M +$149K +2.48% Apr 30, 2019 10-Q 2020-09-08
Q4 2018 $5.14M -$1.26M -19.7% Jan 31, 2019 10-Q 2020-06-09
Q3 2018 $5.18M -$2.74M -34.6% Oct 31, 2018 10-K 2021-01-07
Q2 2018 $6.16M Jul 31, 2018 10-Q 2019-09-06
Q1 2018 $6.02M Apr 30, 2018 10-Q 2019-09-06
Q4 2017 $6.4M Jan 31, 2018 10-Q 2018-03-09
Q3 2017 $7.92M +$6.94M +702% Oct 31, 2017 10-K 2020-01-09
Q3 2016 $987K Oct 31, 2016 10-K 2019-01-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.